<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Nicole M. Batty MD MBA MSF FACP FASCP on Medium]]></title>
        <description><![CDATA[Stories by Nicole M. Batty MD MBA MSF FACP FASCP on Medium]]></description>
        <link>https://medium.com/@nnbattyci?source=rss-bf6559131352------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*HsyDEO9IBe3RMCRS</url>
            <title>Stories by Nicole M. Batty MD MBA MSF FACP FASCP on Medium</title>
            <link>https://medium.com/@nnbattyci?source=rss-bf6559131352------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 23:31:53 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@nnbattyci/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[ SKIN HEALTH | SKIN CANCER AFTER 50 WITH DR.]]></title>
            <link>https://medium.com/@nnbattyci/skin-health-skin-cancer-after-50-with-dr-edd743532f6a?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/edd743532f6a</guid>
            <category><![CDATA[laser]]></category>
            <category><![CDATA[skin]]></category>
            <category><![CDATA[skincare]]></category>
            <category><![CDATA[skin-care-products]]></category>
            <category><![CDATA[cancer]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Sun, 22 Nov 2026 16:12:36 GMT</pubDate>
            <atom:updated>2026-11-22T16:12:36.805Z</atom:updated>
            <content:encoded><![CDATA[<h3>🩺 <strong>SKIN HEALTH | SKIN CANCER AFTER 50 WITH DR. NICOLE M. BATTY</strong><br>✨ <strong>CAN SUN EXPOSURE FROM DECADES AGO STILL AFFECT YOUR SKIN?</strong></h3><p><a href="http://www.e/">www.e</a>chelonmedicalnyc.com</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*c0IQl6CyyCPFon4D6itblA.png" /></figure><p>🩺 <strong>SKIN HEALTH | SKIN CANCER AFTER 50 WITH DR. NICOLE M. BATTY</strong><br>✨ <strong>CAN SUN EXPOSURE FROM DECADES AGO STILL AFFECT YOUR SKIN?</strong> UV damage accumulates, and skin cancer risk rises with age. Estimated annual cases worldwide rose from <strong>1.8 million in 1990 to 6.6 million in 2021</strong>. Adults ages 50–79 carried the greatest burden. In U.S. data from 2015–2019, <strong>men 65 and older</strong> had more than twice the melanoma diagnosis rate of women the same age.<br>🔎 <strong>WHAT SHOULD I LOOK FOR?</strong> <strong>Basal cell carcinoma</strong> usually grows slowly and rarely spreads. <strong>Squamous cell carcinoma</strong> is more likely to spread. <strong>Melanoma</strong> is less common and more likely to spread to other organs. Get a <strong>new or changing spot, a bleeding growth, or a sore that won’t heal</strong> checked. If a dermatologist is hard to see, start with primary care.<br>📅 <strong>DO I NEED A ROUTINE SKIN EXAM?</strong> The U.S. Preventive Services Task Force found <strong>insufficient evidence</strong> to weigh the benefits and harms of routine screening in people without symptoms or a history of precancerous or cancerous skin lesions. Ask about your <strong>personal risk</strong> if you’ve had severe sunburns, substantial UV exposure, skin cancer, many or unusual moles, or a close relative with melanoma.<br>🔬 <strong>WHAT DID THE STUDIES FIND?</strong> Stanford’s referral system helped patients with higher-risk spots get seen about <strong>26 days sooner</strong>. About 15% of people referred for a specific spot had a biopsy, and <strong>28% of those biopsied had skin cancer</strong>. In a separate pilot, an AI tool reduced the number of patients submitting a poor-quality photo for review by <strong>68%</strong>. It checked photo quality. A dermatologist assessed the spot.<br>📸 <strong>CAN NEW TECHNOLOGY FIND MORE MELANOMAS?</strong> A 2025 randomized trial in high-risk patients found that adding <strong>3D body photography and close-up imaging</strong> led to more lesions being removed, with <strong>no statistically significant increase in melanomas detected</strong>. AI and molecular tests are under study. Clinicians still use a lighted magnifier called a <strong>dermatoscope</strong> and biopsy when indicated.<br>🩹 <strong>WHAT IF A BIOPSY FINDS CANCER?</strong> <strong>Mohs surgery</strong> removes thin layers and checks each under a microscope. The Journal cited five-year cure rates of about <strong>99% for previously untreated basal cell carcinoma</strong> and <strong>97% for previously untreated squamous cell carcinoma</strong>. Options can also include radiation, medication, or light-activated treatment. Monitoring may suit some frail older adults with low-risk basal cell cancer.<br>👩‍⚕️ <strong>MY CLINICAL TAKEAWAY.</strong> If a spot is new, changing, bleeding, or slow to heal, I’d want it <strong>evaluated before cosmetic laser treatment</strong>. For daily protection, use shade, a wide-brimmed hat, and broad-spectrum, water-resistant <strong>SPF 30 or higher</strong>. 💬 What would you ask before a skin check?<br>📚 Laura Landro, The Wall Street Journal, Nov. 20, 2026 | wsj.com/health/wellness/skin-cancer-elderly-4cc85e1c<br>Nicole M. Batty, MD, MBA, MSF, FACP, FASCP | Echelon Medical &amp; Aesthetics, Manhattan, NYC | echelonmedicalnyc.com | Text (646) 647–9163<br>#SkinCancerAwareness #MelanomaAwareness #SkinChecks #SunProtection #ManhattanAesthetics</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=edd743532f6a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[ CONCIERGE MEDICINE | ECHELON MEDICAL & AESTHETICS
 HAS THE AI BUBBLE BURST?]]></title>
            <link>https://medium.com/@nnbattyci/concierge-medicine-echelon-medical-aesthetics-has-the-ai-bubble-burst-f0569a1479ab?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/f0569a1479ab</guid>
            <category><![CDATA[manhattan]]></category>
            <category><![CDATA[nyc]]></category>
            <category><![CDATA[concierge]]></category>
            <category><![CDATA[ai]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Sun, 22 Nov 2026 16:03:38 GMT</pubDate>
            <atom:updated>2026-11-22T16:03:38.404Z</atom:updated>
            <content:encoded><![CDATA[<h3>🏥 CONCIERGE MEDICINE | ECHELON MEDICAL &amp; AESTHETICS<br>🚨 HAS THE AI BUBBLE BURST? WHAT THE SELLOFF COULD MEAN FOR HEALTHCARE</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*eKe2fin1-sMRggmgMlDB6g.png" /></figure><p>🏥 CONCIERGE MEDICINE | ECHELON MEDICAL &amp; AESTHETICS<br>🚨 HAS THE AI BUBBLE BURST? WHAT THE SELLOFF COULD MEAN FOR HEALTHCARE<br>📉 THE BIG NEWS<br>On November 22, 2026, The Wall Street Journal’s James Mackintosh compared the AI stock selloff with the dot-com bust. For healthcare, the question is which tools will still get funded, tested and supported if investment slows.<br>🏥 WHAT COULD CHANGE?<br>💰 Hospitals may demand more from pilots before signing contracts. Can the tool reduce missed diagnoses, cut false alarms, or save enough clinician time to justify its cost?<br>🔄 A vendor’s financial health could become a patient-care issue. If a company discontinues a product, clinics need a way to retrieve patient data and keep care moving while they switch systems.<br>🩻 Tools with clinical data may have an edge. A hospital needs to check how a tool works with its own patients, equipment and staff. Savings on paper can disappear if clinicians spend the time correcting errors.<br>🧬 WHAT DOES THE SCIENCE SHOW?<br>🔬 MAMMOGRAPHY. Sweden’s randomized MASAI trial found 6.4 breast cancers per 1,000 screenings with AI support versus 5.0 with standard double reading. AI support also cut the number of screen readings by about 44%. At two years, the study met its prespecified noninferiority criterion for cancers diagnosed between screenings. The effect on breast cancer mortality remains unknown.<br>🔬 AI SCRIBES. In a randomized trial of 238 outpatient physicians, one ambient AI scribe reduced time spent in notes by 9.5% versus usual care. A second tool showed no statistically significant reduction on the same measure. Clinics can use this finding to test whether a specific product saves time once clinicians review and correct the draft.<br>⚠️ WHAT ABOUT SAFETY?<br>The FDA reported more than 1,600 AI-enabled medical devices authorized for U.S. marketing as of September 2026. Every tool has a specific intended use. Health systems should track errors, check performance across patient groups, and make clear who reviews the output before it affects care.<br>⚖️ WHAT PATIENTS SHOULD ASK<br>✅ Where is AI used in my care?<br>✅ Who reviews its output before it affects my diagnosis or treatment?<br>✅ If my visit is recorded, who can access the recording and how long is it kept?<br>🏥 THE ECHELON APPROACH<br>At Echelon Medical &amp; Aesthetics, we emphasize prevention, individualized care, and long-term HEALTHSPAN. We judge technology by whether it improves clinical decisions and gives patients more meaningful time with their physician.<br>✨ REMEMBER<br>A selloff can change which products get funded. Clinical evidence should guide which tools earn a place in patient care.<br>👩‍⚕️ Nicole M. Batty, MD, MBA, MSF, FACP, FASCP<br>Longevity Medicine &amp; Advanced Aesthetics | Manhattan, NYC<br><a href="http://www.echelonmedicalnyc.com/">www.echelonmedicalnyc.com</a> | (646) 647–9163<br>📚 Sources | WSJ (Nov. 22, 2026), MASAI (Lancet Digit Health 2025, Lancet 2026), NEJM AI (2025), FDA (2026).<br>💬 What would build your trust in healthcare AI?<br>#HealthcareAI #PatientSafety #ConciergeMedicine #Healthspan</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f0569a1479ab" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Can a Laser Inside Your Mouth Soften Smile Lines?]]></title>
            <link>https://medium.com/@nnbattyci/can-a-laser-inside-your-mouth-soften-smile-lines-4d8189a6380a?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/4d8189a6380a</guid>
            <category><![CDATA[facelift]]></category>
            <category><![CDATA[laser-hair-removal]]></category>
            <category><![CDATA[dermal-fillers]]></category>
            <category><![CDATA[botox]]></category>
            <category><![CDATA[laser]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Sat, 21 Nov 2026 15:58:44 GMT</pubDate>
            <atom:updated>2026-11-21T15:58:44.635Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*FzWZGpH1jvBkpXSsZkeaIw.png" /></figure><p><em>A Manhattan physician explains what two small studies found, how the treatment feels, and what she looks for during a consultation.</em></p><p><a href="https://youtube.com/shorts/dOYGUC7_REc?feature=share">https://youtube.com/shorts/dOYGUC7_REc?feature=share</a></p><p><strong>By Nicole M. Batty, MD, MBA, MSF, FACP, FASCP</strong></p><p>Sometimes it’s a video call. Sometimes it’s a photo someone took while you were listening. Your face is relaxed, and you notice the lines beside your mouth more than you expected.</p><p>In my Manhattan practice, women often describe what they want in simple terms. They’d like those lines to look a little softer, and they want their smile to look like theirs. One option that surprises them is a laser treatment performed <strong>inside the mouth</strong>.</p><p>It’s called <strong>SmoothLiftin™</strong>, and it’s the first step of Fotona4D®. The treatment raises a good question. If the laser is applied inside the mouth, what change might you see on the outside?</p><h3>What happens inside the mouth?</h3><p>The lines that run from the sides of your nose toward the corners of your mouth are called <strong>nasolabial folds</strong>. They’re a normal part of facial anatomy. During the intraoral step, an erbium:YAG laser delivers heat to the lining of the mouth without removing its surface. The full Fotona4D® protocol also includes external laser steps. The studies I discuss here looked specifically at the intraoral approach. <a href="https://www.fotona.com/media/objave/timewalker_brochure_2019.pdf?utm_source=chatgpt.com">Fotona4D® protocol</a></p><h3>What did researchers actually see?</h3><p>In a randomized pilot study, <strong>13 women completed five monthly sessions</strong>. Each woman had one side of her face treated from inside the mouth and the other side treated through the skin. Comparing both approaches on the same person gave researchers a way to assess how the folds responded.</p><p>Two weeks after the last session, clinicians saw visible improvement on <strong>9 of 13 sides treated inside the mouth</strong> and <strong>10 of 13 sides treated through the skin</strong>. The difference was statistically inconclusive. At four months, clinician ratings still showed no statistically significant difference between the two approaches. <a href="https://doi.org/10.1111/srt.12816">Moftah et al.</a></p><p>The four-month scans showed a difference. The dermis near the fold measured about <strong>270 micrometers</strong> on the side treated inside the mouth and <strong>225 micrometers</strong> on the side treated through the skin. A change in tissue thickness and a change you can see in the mirror are separate outcomes. When a patient asks me how much softer her folds might look, I pay particular attention to what clinicians could see. <a href="https://doi.org/10.1111/srt.12816">Moftah et al.</a></p><p>A second study followed <strong>20 patients</strong> who received six intraoral treatments. Wrinkle scores improved at six months. That study had no untreated comparison group. Taken together, the studies suggest some people may see softening after a series of treatments. They give us less certainty about how much change any individual will see or how long it will last. <a href="https://pubmed.ncbi.nlm.nih.gov/29482388/?utm_source=chatgpt.com">Ebrahim &amp; Gharib</a></p><h3>How does it feel?</h3><p>The upper lip is held up so the handpiece can reach the lining inside the mouth. Holding that position can be uncomfortable. The randomized pilot reported no side effects on the sides treated inside the mouth. With 13 participants completing the study, uncommon side effects are difficult to estimate. In a consultation, I review your medical and oral health history and talk through what the appointment would involve. <a href="https://doi.org/10.1111/srt.12816">Moftah et al.</a></p><h3>The question I ask before we talk about treatment</h3><p><strong>When do you notice the folds most?</strong></p><p>I’ll look at your face at rest and then ask you to smile. If it’s a photo that prompted the visit, show me the photo. What catches your eye when you’re speaking on camera may be different from what you notice in a still image. Knowing which moment matters to you helps us decide whether this approach fits your goal and what we’d look for at follow-up.</p><p>If you could ask one question before trying an intraoral laser, what would it be? <strong>What it feels like, how many visits it takes, or what you might actually see afterward?</strong> I’d like to hear it in the responses.</p><p><strong>Dr. Nicole M. Batty</strong><br>Echelon Medical &amp; Aesthetics · Manhattan, NYC<br><a href="https://echelonmedicalnyc.com/">echelonmedicalnyc.com</a> · Text <strong>(646) 647–9163</strong></p><p>#Fotona #Aerolase #AlmaLasers #Asclepion #BISONMedical #CandelaMedical #Cutera #Cynosure #CynosureLutronic #DEKALaser #ElEnGroup #InMode #JeisysMedical #Laseroptek #Lumenis #Lutronic #LyntonLasers #QuantaSystem #RohrerAesthetics #Sciton #SharpLightTechnologies #SoltaMedical #VenusConcept #Wontech</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4d8189a6380a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[https://youtube.com/shorts/b3hR7UCW0KU?feature=share]]></title>
            <link>https://medium.com/@nnbattyci/https-youtube-com-shorts-b3hr7ucw0ku-feature-share-d612a23cc00c?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/d612a23cc00c</guid>
            <category><![CDATA[botox]]></category>
            <category><![CDATA[filler]]></category>
            <category><![CDATA[manhattan]]></category>
            <category><![CDATA[skincare]]></category>
            <category><![CDATA[med-spa]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Sat, 21 Nov 2026 15:34:48 GMT</pubDate>
            <atom:updated>2026-11-21T15:34:48.879Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*FzWZGpH1jvBkpXSsZkeaIw.png" /></figure><p>🩺 ADVANCED AESTHETICS | FACIAL BALANCING WITH DR. NICOLE M. BATTY</p><p>✨ WHAT WOULD YOU LIKE TO SOFTEN?<br>At Echelon Medical &amp; Aesthetics, I lead your care as a woman physician. I look at how your features work together when your face is relaxed and when you smile or frown. We start with what you love about your face, what you’d like to soften, and how subtle you want the change to be. If there’s one expression or feature you find yourself thinking about, that’s a good place to start the conversation. You can tell me if there’s an area you’d prefer to leave alone. That helps me understand where you’d like us to focus during the visit.</p><p>🔬 WHAT DID THE FROWN-LINE STUDIES FIND?<br>All six FDA-approved cosmetic botulinum toxin brands can temporarily soften glabellar lines, the frown lines between your eyebrows. At about four weeks, these were the percentages of people who met each study’s improvement goal after receiving the product or a placebo injection.</p><p>💉 BOTOX® COSMETIC | 80% vs. 3% had frown lines the clinician rated mild or gone.<br>💉 DYSPORT® | 52–60% vs. 0%<br>💉 XEOMIN® | 48–60% vs. 0%<br>💉 JEUVEAU® | 68–71% vs. 1%<br>💉 DAXXIFY® | 74% vs. 0%<br>💉 LETYBO® | 47–65% vs. 0–2%</p><p>📊 HOW SHOULD YOU READ THE NUMBERS?<br>For the last five brands, both the participant and the clinician had to rate frown lines at least two steps better on a wrinkle scale. Each percentage tells you how many people reached that study’s goal. The trials used somewhat different definitions of improvement, and each product was compared with placebo in separate studies. These percentages can’t tell us which brand will work best for you. At your consultation, we can talk about what you’d consider a meaningful change and how we’d assess it together.</p><p>🧬 WHAT ABOUT COLLAGEN BIOSTIMULATORS?<br>SCULPTRA® (poly-L-lactic acid) helped improve cheek wrinkles by at least one step on a wrinkle scale in 71.6% of assessed participants at 12 months, compared with 26.1% without treatment.</p><p>With RADIESSE® (+) (calcium hydroxylapatite with lidocaine), 75.6% of assessed participants showed a measurable improvement in jawline contour at 12 weeks, compared with 8.8% in the delayed-treatment group.</p><p>These studies measured different outcomes in different areas of the face. One looked at cheek wrinkles and the other at jawline contour. The percentages reflect how often participants met each study’s improvement goal at the time it was assessed. Your result and when you see it will depend in part on your treatment plan. If you’re considering either option, we can discuss what you’d like to see change and when it would make sense to reassess.</p><p>⚠️ THE RISKS MATTER<br>Bruising and swelling can occur after injections. Botulinum toxin can sometimes cause eyelid droop, and fillers carry a rare but serious risk of a blocked blood vessel. Before you decide, we’ll discuss the risks that apply to your plan, what to expect during recovery, and when to contact the office. If you have an event coming up or limited time for recovery, bring that up during your visit so we can factor it into the discussion.</p><p>👩‍⚕️ MY CLINICAL TAKEAWAY<br>Tell me where you’d like to see a change, how subtle you’d like it to be, and which features or expressions you want to preserve. We can talk through what each option might do, how soon you might see a change, and whether starting with one area and reassessing feels right for you. If you’ve had treatment before, I’d like to hear what you liked about the result and what you’d want to approach differently this time.</p><p>🏥 THE ECHELON APPROACH<br>✅ Assess facial proportions at rest and with movement.<br>✅ Review your medical history, allergies, and prior treatments.<br>✅ Discuss expected results, risks, and recovery time.<br>✅ Plan follow-up and agree on what we’ll look for when we reassess.</p><p>💬 What would you like to ask before your first facial balancing consultation? You’re welcome to bring questions about a particular area, the timing of results, or what follow-up would look like. If you’re still deciding what you want, we can start by talking through what you notice and what you’d like to preserve.</p><p>📚 Sources include FDA prescribing information and device reviews, and the published Sculptra cheek-wrinkle trial.</p><p>👩‍⚕️ Nicole M. Batty, MD, MBA, MSF, FACP, FASCP<br>Longevity Medicine &amp; Advanced Aesthetics | Echelon Medical &amp; Aesthetics, Manhattan, NYC<br>🌐 echelonmedicalnyc.com | 📱 Text (646) 647–9163<br>#FacialBalancing #PhysicianLedAesthetics #CollagenBiostimulators #ManhattanAesthetics #EchelonMedicalAndAesthetics</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d612a23cc00c" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[PHYSICIAN-LED AESTHETIC MEDICINE MANHATTAN: WHEN ENOUGH IS ENOUGH]]></title>
            <link>https://medium.com/@nnbattyci/physician-led-aesthetic-medicine-manhattan-when-enough-is-enough-0c1c4f6e92fb?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/0c1c4f6e92fb</guid>
            <category><![CDATA[botox]]></category>
            <category><![CDATA[laser]]></category>
            <category><![CDATA[skincare]]></category>
            <category><![CDATA[manhattan]]></category>
            <category><![CDATA[women]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Thu, 19 Nov 2026 11:12:48 GMT</pubDate>
            <atom:updated>2026-11-19T11:12:48.245Z</atom:updated>
            <content:encoded><![CDATA[<p>November 19, 2026</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*9D_3i--Ul6Uz-zC9" /></figure><h3>Woman Physician-Led Aesthetic Medicine in Manhattan: The Art of Knowing When Enough Is Enough</h3><p><em>What a conversation with a woman from SoHo taught me about beauty, self-worth, and the responsibility to know when not to treat — and why the latest science of rejuvenation and healthy aging makes that judgment more important than ever.</em></p><p>By Nicole M. Batty, MD, MBA, MSF, FACP, FASCP <em>Longevity Medicine &amp; Advanced Aesthetics | Echelon Medical &amp; Aesthetics | Manhattan, New York City</em></p><p>Manhattan has always been a city of reinvention.</p><p>Women here reinvent their careers, their wardrobes, their relationships, and sometimes their entire lives. There is an energy to New York that makes change feel possible at almost any age.</p><p>I understand that impulse. I also understand why a woman might want to look as vibrant as she feels.</p><p>But in aesthetic medicine, I have learned that not every desire for change should lead to another procedure.</p><p>Sometimes, the most important part of my work is understanding what a woman hopes changing her appearance will give her.</p><p>And sometimes, the best thing I can offer is an honest conversation.</p><h3>The Woman From SoHo Who Changed the Conversation</h3><p>A woman from SoHo came to my office after undergoing numerous aesthetic procedures.</p><p>She was considering another treatment. As I examined her face, I could see the effects of her previous procedures, but I did not believe that doing more would improve her overall appearance. In fact, I was concerned that further intervention could disturb the facial harmony she already had.</p><p>Then she told me something I wasn’t expecting.</p><p>She had been pursuing aesthetic treatments because she hoped that becoming more attractive would help her find better romantic partners.</p><p>I remember how that changed the consultation.</p><p>We were no longer talking only about facial proportions or the next treatment. We were talking about relationships, expectations, and what she hoped a more beautiful face might bring into her life.</p><p>As we talked, we recognized that she had begun looking for approval through her appearance. She believed that if she could make herself just a little more attractive, perhaps the right relationship — and the happiness she wanted — would follow.</p><p>I could understand her hope. Most of us want to feel attractive, appreciated, and loved.</p><p>But I was concerned that another procedure would only continue a cycle that wasn’t making her happy.</p><p>I recommended that she stop pursuing additional aesthetic treatments for the time being.</p><p>I couldn’t promise her a better relationship. I couldn’t solve that part of her life through medicine. But I could tell her that, from my clinical perspective, she did not need another procedure.</p><p>That conversation has stayed with me.</p><p>“I want women to feel beautiful because they see something wonderful in themselves — not because they feel they have to change to be loved.”</p><p>I believe women should be free to enjoy aesthetic treatments without feeling that their appearance determines their value.</p><p>The distinction may seem subtle, but it changes how I practice medicine.</p><h3>Why I Believe Aesthetic Medicine Needs a Physician’s Judgment</h3><p>When a woman comes to my office, I don’t begin by looking for something to fix.</p><p>I want to hear what bothers her. I want to know what she has tried before, what she liked, what disappointed her, and what she hopes will be different this time.</p><p>Then I examine her face.</p><p>I look at anatomy, skin quality, facial movement, proportions, and the effects of previous treatments. I consider her medical history and whether a proposed procedure is likely to give her the result she wants.</p><p>Sometimes the answer is straightforward. A small, carefully placed treatment may make a meaningful difference.</p><p>Other times, the answer is more complicated.</p><p>Too much filler can change the natural shape of a face. Too much Botox can soften expressions that are part of a woman’s personality. Repeated procedures may gradually create an appearance she never intended.</p><p>And sometimes, there is simply nothing more I would recommend.</p><p>That is not a failure to offer treatment. It is part of being a physician.</p><p>In a city with medical institutions such as NewYork-Presbyterian/Weill Cornell Medical Center, NYU Langone Health, and Mount Sinai, I believe aesthetic medicine should be approached with the same respect for clinical judgment that we expect in other areas of healthcare.</p><p>At Echelon Medical &amp; Aesthetics in Manhattan, I want women to feel that they can ask questions, express concerns, and receive an honest assessment — even when my recommendation is to wait or do nothing.</p><h3>The Beauty of Looking Like Yourself</h3><p>I have never believed that every woman should have the same lips, cheekbones, or perfectly smooth forehead.</p><p>The women I meet have lived interesting lives. Their faces reflect personality, expression, and experience.</p><p>Why would I want to erase that?</p><p>To me, natural-looking aesthetic medicine is about helping a woman look refreshed without taking away the features that make her recognizable.</p><p>That may mean softening a few lines while keeping the movement around her eyes. It may mean improving skin texture rather than adding volume. It may mean choosing a smaller treatment than she originally requested.</p><p>And sometimes, it means appreciating what is already there.</p><p>The challenge is that aesthetic medicine is evolving quickly. New products and technologies are constantly being introduced, and women are understandably curious about what they can do.</p><p>I am curious, too.</p><p>But excitement about innovation should never replace a careful look at the evidence.</p><h3>Polynucleotides: A New Way of Thinking About Skin Quality</h3><p>For years, aesthetic medicine has focused heavily on wrinkles, volume, and facial contours.</p><p>Now there is growing interest in something more fundamental: the quality and health of the skin itself.</p><p>Polynucleotides are among the treatments being studied for their potential to support skin recovery and hydration.</p><p>A study published in <em>Plastic and Reconstructive Surgery — Global Open</em> in 2026 followed 25 women who received radiofrequency skin treatment. Researchers then treated one side of each woman’s face with polynucleotides and the other side with saline.</p><p>Six weeks later, the side treated with polynucleotides showed greater improvement in pore appearance and wrinkle measurements.</p><p>The skin also retained more moisture and showed less water loss, suggesting better recovery of its protective barrier.</p><p>I find that particularly interesting because patients often tell me they want their skin to look healthier, not simply tighter.</p><p>They want smoother texture, better hydration, and a natural glow.</p><p>This study suggests that polynucleotides may help with some of those goals when used alongside radiofrequency treatment.</p><p>But it was a small study with a short follow-up period. It did not demonstrate significant improvements in skin thickness or elasticity, and it does not prove that polynucleotides reverse aging.</p><p>I see the findings as encouraging early evidence, not a reason to promise dramatic results.</p><h3>Exosomes: Exciting Research, but Not Yet an Established Treatment</h3><p>Exosomes have become a popular topic in aesthetic medicine, partly because of the idea that they may help cells communicate during tissue repair.</p><p>The science is interesting. The marketing, however, often moves faster than the evidence.</p><p>A 2026 study published in the <em>Journal of Craniofacial Surgery</em> followed 60 adults receiving radiofrequency microneedling.</p><p>Researchers applied an extracellular vesicle preparation to one side of each person’s face after treatment, leaving the other side treated with microneedling alone.</p><p>After three months, the side receiving the additional preparation showed greater improvement in wrinkles. Other skin measurements also tended to favor the combination treatment.</p><p>That is worth studying further.</p><p>But we still need to understand which preparations work, how consistently they work, and whether the benefits last.</p><p>The study was relatively short, and the researchers did not establish the biological mechanism responsible for the improvements.</p><p>There is another important point women should know: no exosome products are currently FDA-approved in the United States.</p><p>I believe patients deserve to hear that clearly.</p><p>A treatment can be scientifically promising without being ready for routine clinical use. Women should never feel they are missing out simply because they have not tried the newest product being discussed online.</p><h3>Botox: The Goal Is to Look Refreshed, Not Frozen</h3><h3>Botox is familiar to many women, but the science behind botulinum toxin treatments continues to evolve.</h3><p>In November 2026, researchers published a clinical trial in <em>Plastic and Reconstructive Surgery</em> involving 132 participants and a newer ready-to-use liquid botulinum toxin formulation called relabotulinumtoxinA.</p><p>One month after treatment, approximately 93% of participants receiving the active product reported an improvement in their appearance, compared with about 9% receiving placebo.</p><p>Some noticed improvement within a day, and some continued to report benefits months later.</p><p>These are encouraging findings, although the study did not establish that the formulation is better than every other available botulinum toxin product.</p><p>For me, the more important question is how the treatment looks on the individual woman.</p><p>Can she still smile naturally? Does her face move when she tells a story? Does she look like herself?</p><p>I want women to look rested and comfortable, not frozen or unfamiliar.</p><p>A good result should fit the person — not announce the procedure.</p><h3>Longevity Medicine: What 2026 Research Tells Us About Aging Well</h3><p>One of the things I enjoy most about practicing at the intersection of aesthetics and longevity medicine is that the conversation becomes bigger than appearance.</p><p>Women want to look good, of course. But they also want energy, strength, mental clarity, independence, and the ability to enjoy their lives as they get older.</p><p>Those goals deserve at least as much attention as wrinkles.</p><p>A particularly interesting study published in <em>Nature Medicine</em> in March 2026 looked at something surprisingly ordinary: a daily multivitamin.</p><p>Researchers analyzed 958 older adults, including 482 women, over two years as part of the COSMOS randomized clinical trial.</p><p>They wanted to know whether multivitamins or cocoa extract could influence biological markers associated with aging.</p><p>The participants taking a daily multivitamin showed modestly slower changes in two measures known as epigenetic aging clocks.</p><p>These clocks use patterns in DNA methylation to estimate certain aspects of biological aging.</p><p>The changes were small. The study did not prove that multivitamins make people younger, prevent disease through these biomarker changes, or help them live longer. Cocoa extract did not show a significant effect on the aging measures studied.</p><p>Still, I find the research fascinating.</p><p>It suggests that we are beginning to develop more sophisticated ways of studying how everyday interventions might influence the biology of aging.</p><p>It does not mean everyone should start taking a multivitamin. Individual nutritional needs and medical circumstances still matter.</p><p>And it certainly does not replace what we already know about staying healthy.</p><p>Maintaining muscle through resistance training, protecting cardiovascular health, eating well, sleeping adequately, and keeping up with preventive care remain essential.</p><p>“I love helping women feel good about how they look. But I care just as much about helping them stay healthy and strong enough to enjoy the lives they’ve worked so hard to build.”</p><p>That is what healthy aging means to me.</p><p>It is not about chasing a younger number on a laboratory report. It is about preserving the ability to live well.</p><h3>When Enough Is Enough</h3><p>I think often about the woman from SoHo.</p><p>She came to see me because she believed another aesthetic procedure might bring her closer to the relationship she wanted.</p><p>But during our conversation, it became clear that another treatment was unlikely to give her what she was really looking for.</p><p>I could have discussed additional procedures. Instead, I recommended that she stop for the time being.</p><p>That experience reminded me that aesthetic medicine is not only about knowing how to perform a treatment.</p><p>It is also about knowing when not to.</p><p>“Sometimes the kindest thing I can tell a woman is that she doesn’t need another procedure. She deserves to feel comfortable being herself.”</p><p>I don’t believe women need to choose between caring about their appearance and accepting themselves.</p><p>They can enjoy beauty, fashion, skincare, and aesthetic medicine while knowing that none of those things determines their worth.</p><p>The goal is not to stop women from changing their appearance.</p><p>It is to make sure the decision is truly theirs.</p><h3>A More Thoughtful Future for Aesthetic Medicine</h3><p>I am excited about the future of aesthetic medicine.</p><p>Research into skin recovery, injectable treatments, and the biology of aging is opening possibilities that were difficult to imagine even a decade ago.</p><p>But I hope progress brings more than new procedures.</p><p>I hope it brings more thoughtful consultations, more honest discussions about evidence, and more physicians willing to recommend restraint.</p><p>Women deserve to know what a treatment can accomplish, what remains uncertain, and when the potential benefit may not justify doing more.</p><p>Manhattan will always celebrate reinvention. There is something wonderful about that spirit.</p><p>But a woman should never feel that she must keep reinventing her face to deserve confidence, happiness, or love.</p><p>Sometimes the most beautiful result is not a dramatic transformation.</p><p>It is a woman leaving the consultation knowing that she has been heard, that her choices are respected, and that she is already enough.</p><h3>Frequently Asked Questions</h3><h3>What is woman physician-led aesthetic medicine?</h3><p>Woman physician-led aesthetic medicine is aesthetic care directed by a female physician, with an emphasis on medical assessment, individualized treatment planning, safety, and informed decision-making. The physician considers anatomy, medical history, previous treatments, and personal goals before recommending a procedure.</p><h3>How do I choose an aesthetic medicine physician in Manhattan?</h3><p>Look for appropriate medical qualifications, relevant procedural training, clinical experience, and a consultation that allows time for questions. A physician should explain the benefits, limitations, risks, and alternatives to treatment — including the option of doing nothing.</p><h3>What makes aesthetic results look natural?</h3><p>Natural-looking results respect facial anatomy, expression, and individual proportions. The goal is to address a concern without making a woman look unfamiliar or overtreated.</p><h3>Can Botox look natural?</h3><p>Yes. Careful product selection, dosing, injection technique, and attention to facial movement can help soften wrinkles while preserving expression. Results vary by patient and treatment plan.</p><h3>Can too many aesthetic procedures change the face?</h3><p>Yes. Repeated filler, neuromodulator, or other interventions can produce cumulative changes in facial proportions or expression. Reviewing previous treatments is an important part of planning future care.</p><h3>What are polynucleotides used for in aesthetic medicine?</h3><p>Polynucleotides are being studied for their potential role in improving skin hydration and recovery. Early clinical findings are encouraging, but larger studies with longer follow-up are needed.</p><h3>Are exosome treatments FDA-approved?</h3><p>No exosome products are currently FDA-approved in the United States. Patients should be cautious about broad claims of regeneration or age reversal and discuss the evidence and regulatory status with a qualified physician.</p><h3>What is the difference between aesthetic medicine and longevity medicine?</h3><p>Aesthetic medicine focuses primarily on appearance-related concerns. Longevity medicine focuses on aging-related biology and approaches intended to preserve health and function. The two can complement each other, but looking younger does not necessarily mean aging more slowly.</p><h3>Do multivitamins slow aging?</h3><p>A 2026 randomized trial found modest changes in two epigenetic aging measures among older adults taking daily multivitamins. Researchers have not established that these changes lead to longer life or better health outcomes. Supplementation should be individualized.</p><h3>When should a physician recommend no further aesthetic treatment?</h3><p>A physician may recommend stopping or postponing treatment when the expected benefit is limited, further procedures could compromise natural appearance, or the patient’s goals are unlikely to be met through aesthetic intervention.</p><h3>About the Author</h3><p>Nicole M. Batty, MD, MBA, MSF, FACP, FASCP is a physician focused on longevity medicine and advanced aesthetics at Echelon Medical &amp; Aesthetics in Manhattan, New York City.</p><p>Her approach emphasizes individualized care, natural-looking results, scientific evidence, women’s autonomy, and the importance of recognizing when additional treatment may not be appropriate.</p><p>Echelon Medical &amp; Aesthetics Manhattan, New York City <a href="https://www.echelonmedicalnyc.com/">https://www.echelonmedicalnyc.com/</a> (646) 647–9163</p><h3>Scientific References</h3><ol><li>Kim JS. <em>A Prospective Split-face Trial Evaluating Skin Recovery and Enhancement with Polynucleotide (Rejuran) Following Fractional Needle Radiofrequency Treatment.</em> Plastic and Reconstructive Surgery — Global Open. 2026;14(9):e8109. <a href="https://doi.org/10.1097/GOX.0000000000008109">https://doi.org/10.1097/GOX.0000000000008109</a></li><li>Yen CW, Huang HW, Lin CJ. <em>Radiofrequency Microneedling Combined With Topical Extracellular Vesicle Preparation for Facial Rejuvenation: A Randomized Split-Face Controlled Study.</em> Journal of Craniofacial Surgery. Published online August 24, 2026. <a href="https://doi.org/10.1097/SCS.0000000000013266">https://doi.org/10.1097/SCS.0000000000013266</a></li><li>Schlessinger J, et al. <em>Aesthetic Improvement of Glabellar Lines with Liquid RelabotulinumtoxinA Treatment in a 12-Month Randomized Controlled Study.</em> Plastic and Reconstructive Surgery. Published online November 10, 2026. <a href="https://doi.org/10.1097/PRS.0000000000013599">https://doi.org/10.1097/PRS.0000000000013599</a></li><li>Li S, Hamaya R, Zhu H, et al. <em>Effects of daily multivitamin–multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial.</em> Nature Medicine. 2026;32:1012–1022. <a href="https://doi.org/10.1038/s41591-026-04239-3">https://doi.org/10.1038/s41591-026-04239-3</a></li></ol><p>#SkinPen #SkinPenPrecision #SkinPenMicroneedling #Microneedling #MedicalMicroneedling #Microchanneling #ProCellTherapies #ProCellMicrochanneling #MesoPen #MesoPenPro #ChannelPro #CollagenInductionTherapy #PercutaneousCollagenInduction #CollagenStimulation #CollagenRemodeling #SkinRejuvenation #SkinRegeneration #SkinScience #SkinHealth #SkinTexture #AcneScars #AcneScarTreatment #AtrophicAcneScars #SkinResurfacing #LaserSkinResurfacing #FractionalLaser #FractionalCO2Laser #CO2Laser #ErbiumLaser #ErbiumYAGLaser #NdYAGLaser #AlexandriteLaser #DiodeLaser #PicosecondLaser #PicoLaser #PulsedDyeLaser #VascularLaser #LaserRejuvenation #LaserAesthetics #LaserDermatology #AestheticLasers #MedicalLasers #LaserTechnology #LaserSkinTreatment #LaserSkinRejuvenation #LaserToning #LaserHairRemoval #LaserTattooRemoval #LaserScarTreatment #LaserPigmentationTreatment #LaserAcneTreatment #NonAblativeLaser #AblativeLaser #HybridFractionalLaser #IntensePulsedLight #IPLPhotofacial #Photorejuvenation #Fotona #FotonaLaser #Fotona4D #FotonaDynamis #FotonaSPDynamic #FotonaStarWalker #FotonaTimeWalker #FotonaSmooth #FotonaPiano #FotonaFRAC3 #FotonaNightLase #Lumenis #LumenisAesthetics #LumenisLaser #LumenisUltraPulse #LumenisAcuPulse #LumenisLightSheer #LumenisStellarM22 #LumenisM22 #LumenisResurFX #LumenisSplendorX #UltraPulse #AcuPulse #AlmaLasers #AlmaHarmony #AlmaHarmonyXLPro #AlmaSoprano #AlmaSopranoTitanium #AlmaSopranoICE #AlmaHybrid #AlmaPixel #AlmaClearLift #AlmaDyeVL #AlmaOpus #AlmaOpusPlasma #AlmaAccentPrime #SisramMedical #CandelaMedical #CandelaLaser #GentleMaxPro #GentleMaxProPlus #GentleLase #GentleYAG #GentleProSeries #CandelaPicoWay #PicoWay #PicoWayResolve #Vbeam #VbeamPrima #VbeamPro #Nordlys #CandelaNordlys #ProfoundRF #SyneronCandela #Cynosure #CynosureLutronic #CynosureLaser #PicoSure #PicoSurePro #EliteIQ #ElitePlus #IconLaser #Palomar #PotenzaRF #TempSure #TempSureEnvi #Cutera #CuteraLaser #CuteraExcelV #ExcelVPlus #CuteraEnlighten #EnlightenIII #CuteraAviClear #AviClear #CuteraSecretRF #SecretRF #SecretPRO #CuteraXeo #CuteraTruSculpt #CuteraTitan #Fraxel #FraxelLaser #FraxelDual #ClearAndBrilliant #ClearAndBrilliantTouch #SoltaMedical #Thermage #ThermageFLX #Sciton #ScitonLaser #ScitonHALO #HALOLaser #ScitonBBL #BBLHero #BBLHeroic #BBLForeverYoung #BBLForeverClear #MOXI #MoxiLaser #ScitonSuperMOXI #ScitonJOULE #ScitonJOULEX #ScitonProFractional #ScitonContourTRL #ScitonMicroLaserPeel #DEKA #DEKALaser #DEKAM</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=0c1c4f6e92fb" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[ FDA APPROVES NEW LUNG CANCER DRUG: 49% RESPONSE RATE — BUT DOES IT EXTEND LIFE]]></title>
            <link>https://medium.com/@nnbattyci/fda-approves-new-lung-cancer-drug-49-response-rate-but-does-it-extend-life-cda47f0549da?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/cda47f0549da</guid>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[lung-cancer]]></category>
            <category><![CDATA[concierge-medicine]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[oncology]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Thu, 19 Nov 2026 09:21:15 GMT</pubDate>
            <atom:updated>2026-11-19T09:21:15.419Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ufcvI4Elv_WpRXKSxMi8Bg.png" /></figure><p>🫁 <strong>FDA APPROVES NEW LUNG CANCER DRUG: 49% RESPONSE RATE — BUT DOES IT EXTEND LIFE?</strong><br>🚨 <strong>THE BREAKTHROUGH:</strong> On November 17, 2026, the FDA granted accelerated approval to GSK’s Nelkarmi (neladalkib) for certain patients with previously treated advanced ALK-positive non-small-cell lung cancer (NSCLC).<br>🔬 <strong>THE EVIDENCE:</strong> The phase I/II ALKOVE-1 trial evaluated this ALK inhibitor in patients whose cancer had progressed after prior treatment.<br>📊 <strong>THE FIGURES BEHIND APPROVAL</strong><br>🎯 <strong>49% OBJECTIVE RESPONSE RATE</strong> (33/67; 95% CI 37–62%) in patients previously treated with alectinib as their only ALK inhibitor.<br>📈 <strong>RESPONSE DURABILITY:</strong> Of responders in that group, 76% maintained a response for ≥6 months; 52% for ≥12 months.<br>💊 <strong>32% RESPONSE RATE</strong> (50/155; 95% CI 24–40%) in patients previously treated with ≥2 ALK inhibitors and platinum chemotherapy. Among responders, 69% maintained responses ≥6 months and 51% ≥12 months.<br>🧠 <strong>BRAIN METASTASES:</strong> Intracranial response rates were 55% (11/20) and 26% (14/53) in the respective groups with measurable CNS disease. These were small subgroups.<br>🧬 <strong>WHY IT MATTERS:</strong> ALK-positive lung cancers can develop resistance to targeted therapies. A treatment with activity after prior ALK inhibitors — and against some brain metastases — offers an additional option.<br>⚠️ <strong>SAFETY:</strong> Reported adverse effects included liver toxicity, musculoskeletal pain, constipation, taste changes, neuropathy, edema and fatigue. Risk–benefit assessment remains essential.<br>⚖️ <strong>THE CRITICAL DISTINCTION:</strong> Accelerated approval was based on tumor response and duration — not proof of longer overall survival. ALKOVE-1 was a single-arm trial, so it cannot establish superiority over standard treatment. Confirmatory evidence is needed.<br>🏥 <strong>THE ECHELON PERSPECTIVE:</strong> At Echelon Medical &amp; Aesthetics, we champion precision medicine, appropriate cancer screening and evidence-based innovation. Biomarker-guided care can change treatment decisions — but outcomes that matter to patients must remain the benchmark.<br>✨ <strong>REMEMBER:</strong> Tumor shrinkage is promising. Longer life and better quality of life are the ultimate goals.<br>👩‍⚕️ <strong>Nicole M. Batty, MD, MBA, MSF, FACP, FASCP</strong><br>Longevity Medicine &amp; Advanced Aesthetics<br>📍 Echelon Medical &amp; Aesthetics | Manhattan, NYC<br>🌐 <a href="http://www.echelonmedicalnyc.com/">www.echelonmedicalnyc.com</a> | 📲 (646) 647–9163<br>📚 <strong>Sources:</strong> FDA approval (Nov. 17, 2026); ALKOVE-1 (NCT05384626); WSJ (Nov. 18, 2026).<br>💬 <strong>SHOULD TUMOR RESPONSE BE ENOUGH FOR ACCELERATED APPROVAL — OR SHOULD SURVIVAL DATA COME FIRST?</strong><br>#LungCancer #FDAApproval #PrecisionOncology #ALKPositive #CancerResearch #EvidenceBasedMedicine #EchelonMedicalAndAesthetics</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=cda47f0549da" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[ CONCIERGE MEDICINE | ECHELON MEDICAL & AESTHETICS
 ELI LILLY TO BUY CALYTRIX BIO FOR UP TO $1.5]]></title>
            <link>https://medium.com/@nnbattyci/concierge-medicine-echelon-medical-aesthetics-eli-lilly-to-buy-calytrix-bio-for-up-to-1-5-df9f1f2fd136?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/df9f1f2fd136</guid>
            <category><![CDATA[oncology]]></category>
            <category><![CDATA[concierge-medicine]]></category>
            <category><![CDATA[hematology]]></category>
            <category><![CDATA[blood]]></category>
            <category><![CDATA[manhattan]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Tue, 17 Nov 2026 04:52:45 GMT</pubDate>
            <atom:updated>2026-11-17T04:52:45.911Z</atom:updated>
            <content:encoded><![CDATA[<p>🏥 <strong>CONCIERGE MEDICINE | ECHELON MEDICAL &amp; AESTHETICS</strong><br>🚨 <strong>ELI LILLY TO BUY CALYTRIX BIO FOR UP TO $1.5 BILLION. COULD THIS TRANSFORM BLOOD CANCER TREATMENT?</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_K6Q2DDcUPcodvpABcAnug.png" /></figure><p>🏥 <strong>CONCIERGE MEDICINE | ECHELON MEDICAL &amp; AESTHETICS</strong><br> 🚨 <strong>ELI LILLY TO BUY CALYTRIX BIO FOR UP TO $1.5 BILLION. COULD THIS TRANSFORM BLOOD CANCER TREATMENT?</strong><br> 💰 <strong>THE BIG NEWS:</strong> On November 16, 2026, <em>The Wall Street Journal</em> reported Eli Lilly’s agreement to acquire Calytrix Bio for up to <strong>$1.5 BILLION</strong>, expanding its interest in therapies for myeloproliferative neoplasms (MPNs), a group of rare blood cancers.<br> <strong>But a billion-dollar acquisition does NOT establish clinical efficacy, safety, or FDA approval.</strong><br> 🩸 <strong>WHY DOES THIS MATTER?</strong><br> MPNs involve abnormal blood-cell production and can cause thrombosis, marrow dysfunction, and progression to acute leukemia.<br> Three major subtypes include:<br> 🔬 <strong>1. POLYCYTHEMIA VERA (PV):</strong> Excessive red blood cell production increases thrombotic risk, including stroke and myocardial infarction.<br> 🔬 <strong>2. ESSENTIAL THROMBOCYTHEMIA (ET):</strong> Elevated platelet counts increase risks of thrombosis, bleeding, and disease progression.<br> 🔬 <strong>3. PRIMARY MYELOFIBROSIS (PMF):</strong> Progressive marrow fibrosis can cause anemia, splenomegaly, debilitating symptoms, and leukemic transformation.<br> 🧬 <strong>WHAT DOES THE SCIENCE SHOW?</strong><br> 🔬 <strong>JAK2 MUTATIONS:</strong> Present in approximately <strong>95% of PV</strong> and <strong>50–60% of ET and PMF</strong> cases. These discoveries transformed molecular diagnosis and targeted treatment.<br> 🔬 <strong>RUXOLITINIB:</strong> In the COMFORT-I trial (309 patients), <strong>41.9% achieved ≥35% spleen-volume reduction versus 0.7% with placebo</strong> at 24 weeks.<br> 🔬 <strong>ROPEGINTERFERON ALFA-2b:</strong> PROUD-PV/CONTINUATION-PV demonstrated sustained hematologic and molecular responses in PV, including reductions in JAK2 mutant allele burden.<br> <strong>These findings concern existing treatments and do NOT predict Calytrix Bio’s clinical results.</strong><br> 🚨 <strong>THE NEXT FRONTIER: DISEASE MODIFICATION</strong><br> Can emerging therapies eliminate malignant clones, prevent myelofibrosis or leukemia, reduce thrombosis, and improve survival?<br> <strong>Controlling blood counts is important. Changing the natural history of cancer is the greater ambition.</strong><br> ⚠️ <strong>WHAT ABOUT SAFETY?</strong><br> Investigational MPN therapies require rigorous evaluation for anemia, thrombocytopenia, infection, bleeding, and long-term toxicity. Calytrix’s specific efficacy and safety remain unestablished by this announcement.<br> ⚖️ <strong>WHAT PATIENTS SHOULD ASK</strong><br> ✅ What is my MPN subtype and molecular mutation profile?<br> ✅ What is my thrombosis and progression risk?<br> ✅ Does treatment control symptoms or modify disease?<br> ✅ Am I eligible for clinical trials?<br> 🏥 <strong>THE ECHELON APPROACH</strong><br> At Echelon Medical &amp; Aesthetics, we emphasize precision medicine, prevention, cardiovascular risk reduction, and long-term <strong>HEALTHSPAN</strong>, with specialist coordination for complex hematologic diseases.<br> ✨ <strong>REMEMBER: $1.5 BILLION CAN ACCELERATE DRUG DEVELOPMENT. ONLY RIGOROUS CLINICAL EVIDENCE CAN PROVE BENEFIT AND SAFETY.</strong><br> 👩‍⚕️ <strong>Nicole M. Batty, MD, MBA, MSF, FACP, FASCP</strong><br> Longevity Medicine &amp; Advanced Aesthetics<br> 📍 Echelon Medical &amp; Aesthetics | Manhattan, NYC<br> 🌐 <a href="http://www.echelonmedicalnyc.com/">www.echelonmedicalnyc.com</a><br> 📲 (646) 647–9163<br> 📚 <strong>Sources:</strong> <em>WSJ</em>, Colin Kellaher (Nov. 16, 2026); <em>NEJM</em>, COMFORT-I (2012); <em>Lancet Haematology</em>, PROUD-PV/CONTINUATION-PV (2020).<br> 💬 <strong>COULD THE NEXT GENERATION OF BLOOD CANCER THERAPIES MOVE BEYOND SYMPTOM CONTROL TOWARD TRUE DISEASE MODIFICATION?</strong><br> #EliLilly #CalytrixBio #BloodCancer #MPN #PrecisionMedicine #Hematology #Oncology #JAK2 #LongevityMedicine #Healthspan #EchelonMedicalAndAesthetics</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=df9f1f2fd136" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[ CONCIERGE MEDICINE | ECHELON MEDICAL & AESTHETICS
 ELI LILLY TO BUY CALYTRIX BIO FOR UP TO $1.5]]></title>
            <link>https://medium.com/@nnbattyci/concierge-medicine-echelon-medical-aesthetics-eli-lilly-to-buy-calytrix-bio-for-up-to-1-5-aa68540d3755?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/aa68540d3755</guid>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Tue, 17 Nov 2026 04:51:13 GMT</pubDate>
            <atom:updated>2026-11-17T04:51:13.509Z</atom:updated>
            <content:encoded><![CDATA[<h3>🏥 CONCIERGE <strong>MEDICINE | ECHELON MEDICAL &amp; AESTHETICS</strong><br>🚨 <strong>ELI LILLY TO BUY CALYTRIX BIO FOR UP TO $1.5 BILLION. COULD THIS TRANSFORM BLOOD CANCER TREATMENT?</strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_K6Q2DDcUPcodvpABcAnug.png" /></figure><p>🏥 <strong>CONCIERGE MEDICINE | ECHELON MEDICAL &amp; AESTHETICS</strong><br>🚨 <strong>ELI LILLY TO BUY CALYTRIX BIO FOR UP TO $1.5 BILLION. COULD THIS TRANSFORM BLOOD CANCER TREATMENT?</strong><br>💰 <strong>THE BIG NEWS:</strong> On November 16, 2026, <em>The Wall Street Journal</em> reported Eli Lilly’s agreement to acquire Calytrix Bio for up to <strong>$1.5 BILLION</strong>, expanding its interest in therapies for myeloproliferative neoplasms (MPNs), a group of rare blood cancers.<br><strong>But a billion-dollar acquisition does NOT establish clinical efficacy, safety, or FDA approval.</strong><br>🩸 <strong>WHY DOES THIS MATTER?</strong><br>MPNs involve abnormal blood-cell production and can cause thrombosis, marrow dysfunction, and progression to acute leukemia.<br>Three major subtypes include:<br>🔬 <strong>1. POLYCYTHEMIA VERA (PV):</strong> Excessive red blood cell production increases thrombotic risk, including stroke and myocardial infarction.<br>🔬 <strong>2. ESSENTIAL THROMBOCYTHEMIA (ET):</strong> Elevated platelet counts increase risks of thrombosis, bleeding, and disease progression.<br>🔬 <strong>3. PRIMARY MYELOFIBROSIS (PMF):</strong> Progressive marrow fibrosis can cause anemia, splenomegaly, debilitating symptoms, and leukemic transformation.<br>🧬 <strong>WHAT DOES THE SCIENCE SHOW?</strong><br>🔬 <strong>JAK2 MUTATIONS:</strong> Present in approximately <strong>95% of PV</strong> and <strong>50–60% of ET and PMF</strong> cases. These discoveries transformed molecular diagnosis and targeted treatment.<br>🔬 <strong>RUXOLITINIB:</strong> In the COMFORT-I trial (309 patients), <strong>41.9% achieved ≥35% spleen-volume reduction versus 0.7% with placebo</strong> at 24 weeks.<br>🔬 <strong>ROPEGINTERFERON ALFA-2b:</strong> PROUD-PV/CONTINUATION-PV demonstrated sustained hematologic and molecular responses in PV, including reductions in JAK2 mutant allele burden.<br><strong>These findings concern existing treatments and do NOT predict Calytrix Bio’s clinical results.</strong><br>🚨 <strong>THE NEXT FRONTIER: DISEASE MODIFICATION</strong><br>Can emerging therapies eliminate malignant clones, prevent myelofibrosis or leukemia, reduce thrombosis, and improve survival?<br><strong>Controlling blood counts is important. Changing the natural history of cancer is the greater ambition.</strong><br>⚠️ <strong>WHAT ABOUT SAFETY?</strong><br>Investigational MPN therapies require rigorous evaluation for anemia, thrombocytopenia, infection, bleeding, and long-term toxicity. Calytrix’s specific efficacy and safety remain unestablished by this announcement.<br>⚖️ <strong>WHAT PATIENTS SHOULD ASK</strong><br>✅ What is my MPN subtype and molecular mutation profile?<br>✅ What is my thrombosis and progression risk?<br>✅ Does treatment control symptoms or modify disease?<br>✅ Am I eligible for clinical trials?<br>🏥 <strong>THE ECHELON APPROACH</strong><br>At Echelon Medical &amp; Aesthetics, we emphasize precision medicine, prevention, cardiovascular risk reduction, and long-term <strong>HEALTHSPAN</strong>, with specialist coordination for complex hematologic diseases.<br>✨ <strong>REMEMBER: $1.5 BILLION CAN ACCELERATE DRUG DEVELOPMENT. ONLY RIGOROUS CLINICAL EVIDENCE CAN PROVE BENEFIT AND SAFETY.</strong><br>👩‍⚕️ <strong>Nicole M. Batty, MD, MBA, MSF, FACP, FASCP</strong><br>Longevity Medicine &amp; Advanced Aesthetics<br>📍 Echelon Medical &amp; Aesthetics | Manhattan, NYC<br>🌐 <a href="http://www.echelonmedicalnyc.com/">www.echelonmedicalnyc.com</a><br>📲 (646) 647–9163<br>📚 <strong>Sources:</strong> <em>WSJ</em>, Colin Kellaher (Nov. 16, 2026); <em>NEJM</em>, COMFORT-I (2012); <em>Lancet Haematology</em>, PROUD-PV/CONTINUATION-PV (2020).<br>💬 <strong>COULD THE NEXT GENERATION OF BLOOD CANCER THERAPIES MOVE BEYOND SYMPTOM CONTROL TOWARD TRUE DISEASE MODIFICATION?</strong><br>#EliLilly #CalytrixBio #BloodCancer #MPN #PrecisionMedicine #Hematology #Oncology #JAK2 #LongevityMedicine #Healthspan #EchelonMedicalAndAesthetics</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=aa68540d3755" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Manhattan Woman: Why Being Heard Is Becoming the Ultimate Luxury]]></title>
            <link>https://medium.com/@nnbattyci/the-manhattan-woman-why-being-heard-is-becoming-the-ultimate-luxury-2324e0a5c0e1?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/2324e0a5c0e1</guid>
            <category><![CDATA[skincare]]></category>
            <category><![CDATA[laser]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[beauty]]></category>
            <category><![CDATA[botox]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Mon, 16 Nov 2026 04:27:25 GMT</pubDate>
            <atom:updated>2026-11-16T04:27:25.407Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*wV_uJRBoyOJpWVL7yzOLgA.png" /></figure><p><em>From Fifth Avenue fashion and Michelin-starred dining to physician-led aesthetics and the changing science of midlife health, Manhattan’s modern luxury woman is redefining what it means to live — and age — beautifully.</em></p><p>NEW YORK CITY — Manhattan has perfected the art of anticipating desire.</p><p>A concierge can arrange an impossible reservation. A personal shopper can locate a coveted handbag. A trainer can design a workout around an executive’s demanding schedule. In a city where convenience, discretion and personalization command a premium, almost every preference can become a service.</p><p>Yet there is one experience that many women still struggle to obtain, even when they have access to exceptional resources.</p><p>To be heard.</p><p>Not merely listened to while describing a cosmetic concern, but taken seriously when they explain that their sleep has changed, their energy has declined or their bodies no longer respond as they once did.</p><p>For women navigating their forties, fifties and beyond, these questions often intersect with perimenopause, a biological transition that can affect physical comfort, emotional well-being and daily functioning.</p><p>They also arrive at a moment when the boundaries between luxury wellness, medical aesthetics and preventive healthcare are becoming increasingly blurred.</p><p>The modern Manhattan woman may appreciate a beautifully tailored Chanel jacket, an evening at Le Bernardin or a stay at The Peninsula New York. She may invest in personal training, advanced skincare and sophisticated aesthetic treatments.</p><p>But she is also asking a more consequential question:</p><p>What is the value of looking extraordinary if no one is paying attention to how you actually feel?</p><p>That question is reshaping the conversation about luxury, longevity and women’s health.</p><p>And it suggests that the next frontier of exceptional service may be something medicine should have offered all along: thoughtful, individualized care grounded in evidence, respect and genuine attention.</p><h3>7:00 A.M. | Strength Is the New Status Symbol</h3><p>The day begins before Midtown reaches its full rhythm.</p><p>At Equinox Hudson Yards, members move between strength training, conditioning and recovery. Downtown, Life Time One Wall Street offers an expansive athletic environment inside a landmark building. Chelsea Piers Fitness provides another expression of Manhattan’s premium fitness culture.</p><p>These destinations differ in atmosphere and programming, but they reflect a shared shift in how many women approach exercise.</p><p>The objective is increasingly less about achieving a particular dress size and more about preserving physical capability.</p><p>Resistance training helps maintain muscle strength and function. Aerobic exercise supports cardiovascular fitness. Appropriate weight-bearing activity contributes to skeletal health.</p><p>For women approaching or moving through menopause, these priorities take on added significance.</p><p>Changes in age, hormonal status, activity and other health factors can influence body composition, bone health and physical performance.</p><p>A well-designed exercise program cannot eliminate every biological change, but it can help women maintain strength, mobility and independence.</p><p>Fashion has followed the evolution.</p><p>Nike continues to influence athletic performance and design. Lululemon has helped make premium activewear an everyday wardrobe category. Swiss brand On has brought technical running footwear into contemporary fashion.</p><p>The Manhattan woman may move directly from a morning workout to a professional meeting, combining performance clothing with a tailored coat and understated accessories.</p><p>Her wardrobe accommodates a life that rarely pauses.</p><p>But beneath the polished exterior lies a practical ambition.</p><p>She wants to remain capable of enjoying the life she has worked to create.</p><h3>9:00 A.M. | Fifth Avenue and the Freedom to Define Beauty</h3><p>Few places embody Manhattan’s luxury identity as completely as Fifth Avenue.</p><p>Bergdorf Goodman and Saks Fifth Avenue remain recognizable destinations for fashion. Tiffany &amp; Co. and Cartier represent the city’s enduring relationship with jewelry, craftsmanship and personal milestones.</p><p>The Plaza, The Peninsula New York and The St. Regis New York preserve different traditions of luxury hospitality.</p><p>Nearby, Rockefeller Center brings together architecture, commerce, entertainment and the daily energy of Midtown.</p><p>Fashion houses such as Chanel, Louis Vuitton and Hermès continue to influence the language of luxury through design, heritage and craftsmanship.</p><p>Yet the meaning of elegance is becoming more individual.</p><p>A woman may appreciate an exceptional handbag without believing that her face must remain unchanged.</p><p>She may enjoy dressing beautifully while rejecting the suggestion that visible aging diminishes her worth.</p><p>She may embrace aesthetic treatments, avoid them entirely or change her preferences over time.</p><p>None of those decisions determines her value.</p><p>The distinction is important because the beauty industry has long operated at the intersection of aspiration and insecurity.</p><p>Its most responsible future may depend on understanding that women do not need to be persuaded that aging is a defect before they can be offered a service.</p><p>True luxury expands choice. It does not manufacture inadequacy.</p><h3>11:00 A.M. | A Different Conversation About Medical Aesthetics</h3><p>West of Fifth Avenue, Midtown becomes more intimate.</p><p>The Theater District and Hell’s Kitchen bring together residential streets, restaurants, neighborhood businesses and professional offices within walking distance of Broadway.</p><p>At 393 West 49th Street, Echelon Medical &amp; Aesthetics operates within this landscape.</p><p>Led by Dr. Nicole M. Batty, MD, MBA, MSF, FACP, FASCP, the practice describes a physician-led approach to medical aesthetics, with an emphasis on individualized assessment and natural-looking results.</p><p>According to Echelon’s published professional information, Dr. Batty’s background includes internal medicine, hematology, oncology, clinical research and preventive medicine.</p><p>The practice’s stated philosophy reflects an important principle in aesthetic medicine: recommendations should be based on the individual rather than on a standardized treatment package.</p><p>A woman may be concerned about pigmentation, skin texture, facial volume or selected changes in firmness.</p><p>She may be interested in lasers, injectables or collagen-stimulating procedures.</p><p>Or she may simply want an informed assessment of whether a procedure would be worthwhile.</p><p>The appropriate response should depend on her anatomy, medical history, goals and risk tolerance.</p><p>Not on the number of treatments available for purchase.</p><p>For a woman accustomed to managing professional responsibilities, family obligations and constant decisions, an appointment focused on her own concerns may feel meaningful.</p><p>But a medical consultation should offer more than an elevated customer experience.</p><p>It should provide clinical judgment.</p><h3>The Technology Behind the New Aesthetic Landscape</h3><p>Non-surgical aesthetic medicine has expanded considerably through advances in lasers, light-based systems, ultrasound, radiofrequency and injectable treatments.</p><p>Echelon identifies Fotona SP Dynamis and Fotona StarWalker among its laser platforms.</p><p>Fotona SP Dynamis combines Er:YAG and Nd:YAG wavelengths, which may be used in selected protocols involving skin resurfacing, texture and collagen remodeling.</p><p>Fotona 4D® incorporates intraoral and external laser applications for selected facial rejuvenation concerns.</p><p>Other protocols associated with Fotona technology include SmoothEye®, LipLase® and TightSculpting®.</p><p>Fotona StarWalker uses specialized short-pulse laser technology for selected pigmentation concerns, tattoo removal and other aesthetic applications.</p><p>A practice’s possession of a laser platform does not establish that every associated branded protocol is offered, clinically appropriate or supported by identical evidence.</p><p>Across the wider industry, Sciton BBL HEROic uses broadband light for selected concerns involving redness, pigmentation and photodamage.</p><p>Moxi employs non-ablative fractional laser technology for certain textural and pigmentary concerns.</p><p>Sofwave uses ultrasound energy for selected wrinkles and mild skin laxity.</p><p>Morpheus8 combines radiofrequency energy with microneedling for certain skin-texture and tissue-remodeling applications.</p><p>Injectable treatments represent another category.</p><p>Neuromodulators such as Botox, Dysport and Xeomin can temporarily soften selected expression lines.</p><p>Dermal fillers may address particular contour or volume concerns.</p><p>Sculptra is a biostimulatory injectable used for appropriate indications involving gradual collagen stimulation.</p><p>Other technologies include CoolSculpting for selected localized fat concerns and Candela GentleMax Pro Plus for applications such as laser hair reduction.</p><p>Echelon’s published service information also identifies Morpheus8, injectable treatments and other selected skin-rejuvenation procedures.</p><p>These technologies are not interchangeable.</p><p>A laser cannot reproduce every effect of an injectable. A non-surgical tightening treatment does not replace a surgical facelift. A treatment suitable for one skin type or medical history may be inappropriate for another.</p><p>Potential complications include burns, pigmentary changes, infection and, with certain injectable procedures, rare but serious vascular events.</p><p>In responsible aesthetic medicine, the treatment plan begins with clinical assessment — not the device menu.</p><h3>When Innovation Outpaces Evidence</h3><p>The popularity of regenerative aesthetics illustrates another challenge.</p><p>Interest in collagen stimulation and tissue remodeling has brought attention to platelet-derived treatments, biostimulatory injectables and emerging biological products.</p><p>But the evidence varies by intervention and indication.</p><p>Platelet-rich fibrin is being explored for selected aesthetic applications, although supporting research remains less established for some uses.</p><p>Exosome-based products have generated commercial interest, but the U.S. Food and Drug Administration has warned about unapproved exosome products and their potential risks.</p><p>The distinction between scientific possibility and established treatment matters.</p><p>A sophisticated patient deserves to know not only what a procedure is intended to accomplish, but also what has been demonstrated, what remains uncertain and what alternatives exist.</p><p>The future of medical aesthetics should be defined by better evidence — not simply more innovation.</p><h3>12:30 P.M. | The Midlife Health Conversation Women Deserve</h3><p>The most consequential change in women’s wellness may have little to do with aesthetics.</p><p>It concerns perimenopause.</p><p>For some women, the transition begins with disrupted sleep.</p><p>A woman who previously slept comfortably may begin waking during the night. Menstrual cycles may become less predictable. Hot flashes or night sweats may interfere with daily life.</p><p>Others notice vaginal dryness, changes in mood, difficulty concentrating or alterations in sexual and urinary health.</p><p>Experiences vary considerably.</p><p>Some women have few symptoms. Others experience significant disruptions that affect work, relationships and quality of life.</p><p>The Menopause Society’s 2023 nonhormone therapy position statement reports that hot flashes and night sweats occur in up to 80% of menopausal women and that bothersome symptoms may persist for years.</p><p>These are not merely cosmetic concerns.</p><p>They can affect how women function and feel.</p><p>Yet women may encounter incomplete evaluations or explanations that minimize their experiences.</p><p>For a professional who manages complex decisions every day, struggling to obtain clear guidance about her own health can be particularly frustrating.</p><p>A woman who can lead a company, manage a household or care for an entire family should not have to fight to have her symptoms taken seriously.</p><p>Perimenopause is a natural biological transition, not a disease.</p><p>Not every woman requires treatment.</p><p>But symptoms that interfere with quality of life deserve thoughtful medical evaluation.</p><p>The Menopause Society identifies hormone therapy as the most effective treatment for menopausal hot flashes and night sweats in appropriately selected patients.</p><p>Evidence-based nonhormonal options are also available, including certain prescription medications, cognitive-behavioral therapy and clinical hypnosis.</p><p>Treatment decisions depend on symptoms, medical history, contraindications and patient preferences.</p><p>Some women also require evaluation for other conditions that can produce similar symptoms.</p><p>The objective is not to medicalize every aspect of midlife.</p><p>It is to ensure that women have access to accurate information and appropriate choices.</p><h3>Looking Well Is Not the Same as Feeling Well</h3><p>Hormonal changes around menopause can influence skin hydration, collagen and tissue characteristics.</p><p>Some women notice dryness, reduced firmness or changes in hair growth.</p><p>But aging is influenced by many factors, including genetics, ultraviolet exposure, nutrition, medications and underlying medical conditions.</p><p>A woman may reasonably choose an aesthetic treatment to address a particular appearance-related concern.</p><p>That decision is separate from the medical management of perimenopause.</p><p>A laser cannot correct systemic hormonal symptoms.</p><p>An injectable does not resolve persistent night sweats.</p><p>And a cosmetic procedure should never be presented as a substitute for evidence-based menopause care.</p><p>This distinction is essential as the language of wellness increasingly blends medical treatment, beauty services and lifestyle experiences.</p><p>The most credible approach recognizes the boundaries between them.</p><h3>2:00 P.M. | What a Safe Space Actually Means</h3><p>Consider an illustrative Manhattan professional in her late forties.</p><p>She has spent years building a career, supporting family members and managing a demanding schedule.</p><p>Recently, she has noticed changes in her sleep, energy and appearance.</p><p>She books an aesthetic consultation, initially intending to discuss facial rejuvenation.</p><p>But as the conversation develops, her questions become broader.</p><p>Why does she feel different?</p><p>Could perimenopause be contributing?</p><p>Which changes are cosmetic, and which deserve medical evaluation?</p><p>What can a treatment realistically accomplish?</p><p>The most important part of the appointment may be the opportunity to ask those questions without embarrassment.</p><p>This is a hypothetical scenario, not a patient testimonial.</p><p>It illustrates why a welcoming clinical environment matters — and why genuine safety requires more than welcoming language.</p><p>Echelon describes its philosophy as physician-led and individualized, with an emphasis on patient education and thoughtful treatment planning.</p><p>Those are relevant principles, but a safe space cannot be established by branding or décor alone.</p><p>It requires clinical competence, appropriate screening, informed consent, transparency about risks and respect for the patient’s right to decline treatment.</p><p>Medical aesthetics operates within a commercial marketplace.</p><p>Additional procedures generate revenue, creating an ethical obligation to ensure that treatment recommendations are driven by patient interests rather than sales incentives.</p><p>Physician involvement can contribute to medical oversight, but credentials alone do not guarantee superior outcomes.</p><p>The real measure of care is whether patients receive accurate information, appropriate treatment and respect.</p><p>A woman should leave a consultation understanding her options — not feeling that she has acquired another reason to criticize herself.</p><h3>3:30 P.M. | Midtown’s Cultural Interlude</h3><p>Outside, Manhattan continues its familiar rhythm.</p><p>At Rockefeller Center, visitors move beneath the Art Deco towers.</p><p>Radio City Music Hall remains a recognizable landmark of the city’s entertainment history.</p><p>The Museum of Modern Art offers a quieter encounter with modern and contemporary art.</p><p>Carnegie Hall represents Manhattan’s longstanding musical heritage.</p><p>Nearby, The Modern brings fine dining into conversation with MoMA’s cultural setting.</p><p>The Polo Bar offers another expression of Midtown hospitality, while The Lambs Club reflects the neighborhood’s theatrical history.</p><p>These institutions give Midtown a character that cannot be reproduced by generic descriptions of luxury.</p><p>It is not simply a neighborhood of boutiques and office towers.</p><p>It is a place where commerce, culture, ambition and everyday life intersect.</p><p>For the Manhattan woman, the afternoon may include a business meeting, an exhibition, lunch with a friend or a rare hour without obligations.</p><p>That hour may be more valuable than anything she could purchase during it.</p><h3>7:30 P.M. | The Pleasure of an Exceptional Evening</h3><p>As daylight fades, Manhattan’s restaurant culture takes center stage.</p><p>Le Bernardin remains celebrated for its seafood-focused French cuisine.</p><p>Eleven Madison Park is known for contemporary culinary creativity and carefully designed hospitality.</p><p>Per Se, overlooking Columbus Circle and Central Park, offers an elaborate tasting-menu experience associated with precision and service.</p><p>These destinations represent different expressions of Manhattan fine dining rather than a definitive ranking.</p><p>Their appeal lies in experience.</p><p>A memorable meal may celebrate a professional achievement, deepen a friendship or offer a pause in a demanding week.</p><p>For women navigating midlife, balanced nutrition, adequate protein and attention to bone health remain important considerations.</p><p>But wellness should not require turning every meal into an exercise in optimization.</p><p>Pleasure, conversation and celebration belong in a fulfilling life.</p><p>An exceptional dinner is not a medical intervention.</p><p>It does not need to be one.</p><h3>10:00 P.M. | Manhattan After Dark</h3><p>New York’s nightlife offers another expression of the city’s personality.</p><p>At Bemelmans Bar inside The Carlyle, illustrated murals and live piano music evoke classic Manhattan elegance.</p><p>The Campbell, within Grand Central Terminal, combines historic architecture with cocktail-lounge hospitality.</p><p>In the West Village, Employees Only remains associated with the city’s influential contemporary cocktail culture.</p><p>For women seeking dancing and electronic music, Marquee New York in Chelsea, Le Bain at The Standard, High Line and Nebula in Midtown offer distinct nightclub experiences.</p><p>These destinations reflect Manhattan’s variety rather than a ranking of its best venues.</p><p>The modern luxury woman may enjoy a quiet evening with friends, a Broadway performance, a sophisticated bar or a dance floor.</p><p>She may also choose to go home early.</p><p>For women experiencing sleep disruption or vasomotor symptoms, restorative sleep may be especially important.</p><p>Alcohol can worsen symptoms for some individuals and carries broader health risks.</p><p>A sophisticated lifestyle is not defined by participating in every available experience.</p><p>It is defined by the freedom to choose.</p><h3>The Business of Trust</h3><p>Manhattan’s luxury economy excels at personalization.</p><p>A hotel remembers a guest’s preferences.</p><p>A fashion house offers craftsmanship and identity.</p><p>A fitness club adapts programming to individual goals.</p><p>But healthcare must meet a higher standard.</p><p>A medical practice must determine whether a proposed intervention is appropriate, explain its risks, consider alternatives and protect the patient’s autonomy.</p><p>This distinction is particularly important in medical aesthetics, where elective procedures are delivered within a commercial environment.</p><p>The industry’s long-term credibility will depend on more than new devices and increasingly sophisticated treatment menus.</p><p>It will depend on clinical judgment, responsible patient selection, transparent communication and realistic expectations.</p><p>For Echelon Medical &amp; Aesthetics, its published commitment to physician-led, individualized care offers one example of how an aesthetic practice can position itself around these principles.</p><p>Whether that commitment is fulfilled consistently must be demonstrated through actual clinical practice and patient experience — not assumed from marketing claims.</p><p>The same standard applies throughout the industry.</p><p>Listening is not a luxury amenity. In healthcare, it is a professional responsibility.</p><h3>The New Definition of Aging Beautifully</h3><p>The modern Manhattan woman is not a single archetype.</p><p>She may be forty-two or sixty-five.</p><p>She may be raising children, leading an organization, building a business, beginning a second career or rediscovering interests she once set aside.</p><p>She may enjoy fashion, fitness, travel, fine dining and medical aesthetics.</p><p>Or she may prefer a quieter life.</p><p>What connects these experiences is not a particular income, appearance or social calendar.</p><p>It is the desire for autonomy.</p><p>A woman should be able to seek treatment for bothersome perimenopausal symptoms without being dismissed.</p><p>She should be able to consider aesthetic procedures without being pressured.</p><p>She should be able to age naturally without feeling that she has failed to care for herself.</p><p>And she should have access to healthcare professionals who recognize the difference between supporting her decisions and making those decisions for her.</p><p>The newest laser technology may improve selected aesthetic concerns.</p><p>Strength training may help preserve physical function.</p><p>Fine dining, fashion, art and nightlife may enrich her experience of the city.</p><p>But none of these replaces the value of being respected.</p><h3>The Ultimate Luxury Is a Life That Belongs to You</h3><p>Manhattan will always celebrate ambition.</p><p>Its fashion houses will continue to inspire. Its restaurants will innovate. Its cultural institutions will shape conversations far beyond New York.</p><p>Medical aesthetics will continue to develop technologies that expand the options available to patients.</p><p>Yet for women navigating midlife, the most meaningful transformation may be less visible.</p><p>It is the recognition that aging does not diminish a woman’s individuality, ambition or right to excellent care.</p><p>Dr. Nicole M. Batty’s stated approach at Echelon Medical &amp; Aesthetics reflects one part of this broader conversation: the importance of combining individualized aesthetic assessment with medical judgment and respect for patient choice.</p><p>The larger message extends beyond Midtown Manhattan.</p><p>Women deserve to be heard when their health changes. They deserve honest information when considering aesthetic treatment. And they deserve the freedom to define beauty, wellness and success on their own terms.</p><p>Because the ultimate luxury is not a younger face, a perfect wardrobe or a reservation at Manhattan’s most exclusive table.</p><p>It is something more personal — and far more enduring.</p><p>The confidence to live fully. The freedom to choose wisely. And the assurance that your voice matters at every age.</p><h3>Featured Physician and Practice</h3><p>Dr. Nicole M. Batty, MD, MBA, MSF, FACP, FASCP</p><p>Echelon Medical &amp; Aesthetics<br>393 West 49th Street, TH1E<br>New York, NY 10019</p><p>Website: <a href="https://www.echelonmedicalnyc.com/">https://www.echelonmedicalnyc.com</a></p><p><em>Editorial disclosure: Descriptions of Echelon and Dr. Batty’s professional background are based on the practice’s published information. No independent patient outcomes, physician interviews, patient testimonials or business endorsements are claimed.</em></p><p>#TheManhattanWoman #EchelonMedicalAndAesthetics #DrNicoleBatty #EchelonMedicalNYC #ManhattanLuxury #NewYorkCity #NYCLifestyle #LuxuryLifestyle #LuxuryWellness #WomensHealth #WomensWellness #Perimenopause #MenopauseAwareness #HealthyAging #Longevity #MedicalAesthetics #PhysicianLedCare #FifthAvenue #MidtownManhattan #HellskitchenNYC #TheaterDistrict #BergdorfGoodman #SaksFifthAvenue #TiffanyAndCo #Cartier #Chanel #LouisVuitton #Hermes #ThePlazaHotel #ThePeninsulaNewYork #StRegisNewYork #RockefellerCenter #Equinox #EquinoxHudsonYards #LifeTimeFitness #LifeTimeOneWallStreet #ChelseaPiersFitness #Nike #Lululemon #OnRunning #Fotona #FotonaSPDynamis #FotonaStarWalker #Fotona4D #SmoothEye #LipLase #TightSculpting #Sciton #BBLHeroic #MoxiLaser #Sofwave #Morpheus8 #Botox #Dysport #Xeomin #Sculptra #CoolSculpting #Candela #GentleMaxProPlus #RadioCityMusicHall #MuseumOfModernArt #MoMA #CarnegieHall #TheModernNYC #ThePoloBar #TheLambsClub #LeBernardin #ElevenMadisonPark #PerSeNYC #BemelmansBar #TheCarlyle #TheCampbellNYC #GrandCentralTerminal #EmployeesOnlyNYC #MarqueeNYC #LeBainNYC #TheStandardHighLine #NebulaNYC #TheMenopauseSociety #FDA #WomensEmpowerment #WomenDeserveToBeHeard #AgingBeautifully #BeautyWithConfidence #PersonalizedMedicine #PatientCenteredCare #LuxuryBeauty #NYCBeauty #MidlifeWellness #StrengthTrainingForWomen #EvidenceBasedMedicine #NaturalLookingResults #SkinRejuvenation #RegenerativeAesthetics #ConfidenceAtEveryAge</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2324e0a5c0e1" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[ CONCIERGE MEDICINE | AI IN HEALTHCARE & PRECISION MEDICINE
  NO MORE AI SHAMING!]]></title>
            <link>https://medium.com/@nnbattyci/concierge-medicine-ai-in-healthcare-precision-medicine-no-more-ai-shaming-f68b6e5b6f92?source=rss-bf6559131352------2</link>
            <guid isPermaLink="false">https://medium.com/p/f68b6e5b6f92</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[medical]]></category>
            <category><![CDATA[ai]]></category>
            <category><![CDATA[diagnosis]]></category>
            <category><![CDATA[physicians]]></category>
            <dc:creator><![CDATA[Nicole M. Batty MD MBA MSF FACP FASCP]]></dc:creator>
            <pubDate>Sun, 15 Nov 2026 06:41:20 GMT</pubDate>
            <atom:updated>2026-11-15T06:41:20.635Z</atom:updated>
            <content:encoded><![CDATA[<h3>🩺 <strong>CONCIERGE MEDICINE | AI IN HEALTHCARE &amp; PRECISION MEDICINE</strong><br> 🚨🧠 <strong>NO MORE AI SHAMING! WHAT IF AI RECOGNIZES A MEDICAL CONDITION THAT HAS BEEN MISSED FOR DECADES?</strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*xwzYWB5btnl6qe6Xe_wDbw.png" /></figure><p>🩺 <strong>CONCIERGE MEDICINE | AI IN HEALTHCARE &amp; PRECISION MEDICINE</strong><br> 🚨🧠 <strong>NO MORE AI SHAMING! WHAT IF AI RECOGNIZES A MEDICAL CONDITION THAT HAS BEEN MISSED FOR DECADES?</strong><br> Patients deserve to be heard — not dismissed for researching their own symptoms! 👀<br> 📰 <strong>THE WALL STREET JOURNAL (NOV. 12, 2026)</strong>: “How AI Diagnosed a Medical Mystery My Doctors Missed for Decades” — Katherine Bindley.<br> 🔍 <strong>WHAT HAPPENED?</strong> After years of severe abdominal pain, migraines, heavy menstrual bleeding, fatigue, and low iron, the author turned to Google’s Gemini AI. Her ferritin had fallen to <strong>7 ng/mL</strong>. AI connected her medical history to possible <strong>ENDOMETRIOSIS &amp; ADENOMYOSIS</strong> — conditions that previous evaluations had not established.<br> 🩻 Despite negative imaging, further specialist evaluation identified findings concerning for endometriosis. Three specialists agreed with the suspected diagnoses, although definitive confirmation remained outstanding.<br> 🔬 <strong>WHAT DOES THE SCIENCE SHOW?</strong><br> 📊 <strong>10% OF WOMEN</strong>: Endometriosis affects approximately <strong>1 in 10 women of reproductive age</strong>.<br> ⏳ <strong>8–12 YEARS</strong>: Diagnostic delays of this magnitude have been reported in endometriosis, although estimates vary substantially.<br> 🚨 <strong>795,000 ANNUALLY</strong>: A 2024 U.S. modeling study estimated approximately <strong>795,000 cases of death or permanent disability annually associated with diagnostic errors</strong> (plausible range: 598,000–1,023,000).<br> 🤖 <strong>92% AI REASONING SCORE</strong>: A 2024 randomized study involving <strong>50 physicians</strong> found that GPT-4 alone achieved a median <strong>92% diagnostic reasoning score</strong> on selected clinical cases.<br> 👩‍⚕️ <strong>76% VS. 74%</strong>: Physicians using AI scored 76% versus 74% with conventional resources — a difference that was <strong>NOT statistically significant (p=0.60)</strong>.<br> ⚠️ <strong>AI CAN ALSO MISLEAD</strong>: A 2026 randomized trial involving <strong>44 physicians</strong> found diagnostic accuracy fell to <strong>73.3% versus 84.9%</strong> when physicians were exposed to deliberately incorrect AI suggestions.<br> 🔥 <strong>WHY SHOULD WE STOP AI SHAMING?</strong><br> ✨ Patients can organize years of symptoms and medical records.<br> ✨ AI may suggest overlooked possibilities worth investigating.<br> ✨ Patients can prepare more informed questions for appointments.<br> ✨ Physicians can evaluate AI-generated suggestions against clinical findings and established evidence.<br> ✨ Shared decision-making can improve when patients feel comfortable discussing their research.<br> ⚠️ <strong>BUT AI IS NOT A DOCTOR!</strong><br> 🔹 A plausible diagnosis ≠ a confirmed diagnosis.<br> 🔹 High benchmark scores ≠ reliable real-world clinical performance.<br> 🔹 AI can invent facts, exaggerate certainty, or reinforce incorrect assumptions.<br> 🔹 Physical examinations, imaging, laboratory testing, and specialist expertise remain essential.<br> 🔹 Sensitive medical records should be shared only with appropriate privacy safeguards.<br> 🏥 <strong>THE ECHELON CONCIERGE MEDICINE APPROACH</strong>: At <strong>Echelon Medical &amp; Aesthetics</strong>, we support informed patients, thoughtful second opinions, longitudinal review of complex symptoms, and responsible use of emerging technologies.<br> 👩‍⚕️ <strong>MY CLINICAL TAKEAWAY</strong>: As a physician, I would rather have a patient bring me <strong>10 AI-generated questions</strong> than remain silent about symptoms that have never been adequately explained.<br> The answer is not to shame patients — or blindly trust algorithms. It is to combine <strong>HUMAN CLINICAL JUDGMENT + PATIENT ADVOCACY + RESPONSIBLE AI</strong>.<br> 💥 <strong>NO MORE AI SHAMING. NO MORE DISMISSING PATIENTS. BETTER QUESTIONS CAN LEAD TO BETTER DIAGNOSES!</strong><br> 📚 <strong>SOURCES</strong>: WSJ, Katherine Bindley (Nov. 12, 2026); Goh et al., <em>JAMA Network Open</em> (2024); Newman-Toker et al., <em>BMJ Quality &amp; Safety</em> (2024); Qazi et al., <em>NEJM AI</em> (2026).<br> 💬 <strong>SHOULD PHYSICIANS ENCOURAGE PATIENTS TO DISCUSS AI-GENERATED HEALTH QUESTIONS DURING THEIR APPOINTMENTS?</strong> 👇<br> 👩‍⚕️ <strong>Nicole M. Batty, MD, MBA, MSF, FACP, FASCP</strong><br> Longevity Medicine &amp; Advanced Aesthetics | Board-certified in Internal Medicine, Pathology, Medical Oncology &amp; Hematology<br> 📍 <strong>Echelon Medical &amp; Aesthetics, Manhattan, NYC</strong> | echelonmedicalnyc.com<br> 📲 <strong>Text (646) 647–9163</strong><br> #NoMoreAIShaming #AIinHealthcare #PatientAdvocacy #DiagnosticAccuracy #Endometriosis #PrecisionMedicine #ConciergeMedicine #MedicalInnovation #EvidenceBasedMedicine #EchelonMedicalAndAesthetics</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f68b6e5b6f92" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>